Introduction -The case for a hermeneutic approach to biological investigation
From slime mold to the rhesus macaque, countless species have contributed to our current understanding of the biological processes that grant life. The optimum animal model for a line of research is often determined by a particular anatomical feature that makes the organism uniquely suitable for experimentation. For example, although the giant squid may seem an unusual choice to further understanding of mammalian neural circuits, the sheer size and slow conduction velocity of its axons enabled scientists to study neuronal firing with the rudimentary electrophysiological techniques available during the early 20th century [1] , giving rise to the field of modern cellular neuroscience. By examining individual aspects of a diverse range of organisms in great detail, scientists have been able to amass a set of unifying principles for the field of neural sciences [2] . The route to this understanding parallels the hermeneutic circle, a classic concept in theology and logic [3] . In hermeneutics, the process of interpretation follows a spiraling path in which one first studies the overall body, then examines its composite parts, and lastly revisits the concept of the whole body as a sum of the parts. Similarly, in neuroscience, observation of a particular sensory or motor system in an organism leads to investigation of the cellular underpinnings of the related circuits, which are then placed in the larger context of the central and peripheral nervous systems.
Applying this approach to investigations of molecular and cellular physiology in health and disease can be both technologically challenging and time-consuming in mammalian subjects. Mammalian tissues can be easily photographed at the macroscopic level, and then the organs and tissues can be dissected and thinly sliced for microscopic analysis. However, the process of aligning these two different perspectives to reconstruct a whole-organism map with subcellular resolution remains nontrivial [4] . Without a clear methodology for integrating microscale and macroscale views, it is difficult to apply newly-discovered molecular mechanisms to systems-level questions and to recognize how systems-level findings may in turn inform novel hypotheses on molecular processes.
Two recent technical advances can bridge the divide between cellular and systems-level studies (Table 1) . First, improved viral-vector-based strategies can deliver cargo, such as fluorescent labels, efficiently and with cell specificity over entire organs or the whole body ( Figure 1 ). This enables tracing of, for example, widecoverage brain networks or peripheral nerves ([5 ,6,7,8 ,9-13,14 ], reviews: [15] [16] [17] [18] [19] [20] ). Second, optimized tissue-clearing methodologies (Tables 2 and 3 , with key terminology defined in Box 1) can map intact local and long-range circuits [ [67] [68] [69] [70] [71] , and tissuebinding size-adjustable polymeric scaffolding [22 ,29 , 32 ,37,41 ,72 ] (for review: [73] ). This brief review will highlight recent work on generating adeno-associated viruses (AAVs) with unique properties via specialized viral-vector screening methods [53 , [74] [75] [76] [77] [78] [79] [80] (Figure 1 , Box 1), and on modern tissue-clearing methodologies that preserve fluorescence and support high-resolution imaging at depth (Figure 2 Scientific motivation for broad coverage gene delivery and imaging of whole intact tissues in mammals by tissue clearing
Although viral vectors are commonly used for delivering genetically encoded cargo to mammalian cells in vivo, therefore avoiding slow and costly transgenic means, few are capable of both safe and efficient transduction of specific cellular targets. Fewer still are capable of broad coverage across all cellular connectivity under study. For example, AAVs are widely used, especially in nondividing cells, due to their safety [78, [84] [85] [86] ; however, the handful of serotypes available cannot efficiently and specifically target many populations of interest. Past and ongoing efforts on engineering viral vectors with desired properties [79, 87, 88] , including cell-type and/or organ specificity [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] , will greatly benefit research in tissue mapping, gene therapy, and genome editing [90] . To contribute to and complement these efforts we have recently developed an in vivo Cre-REcombination-based AAV Targeted Evolution (CREATE) selection platform for identifying AAVs that more efficiently transduce genetically defined cell populations (Figure 1a) [53 ]. We used CREATE to identify variants from a systemically delivered AAV capsid library that cross the blood-brain barrier and transduce neurons and astrocytes brain-wide. Using this method, we identified one variant, AAV-PHP.B, 1 that achieves 40-fold to 90-fold more efficient brain-wide transduction than the current standard, AAV9 (Figure 1d ) [91] . AAV-PHP.B transduces most neuronal types and glia throughout the brain, which supports its use to deliver multicolor labels to genetically defined circuits for 194 Tissue, cell and pathway engineering Whole-body clearing a of rodents (embryo through aged adult; see Figure 1 ) Excised whole-organ delipidation through major blood vessels in larger mammalian subjects (e.g., pigs, nonhuman primates) [102, 152] CREATE platform for viral vector screening in cleared samples (Figure 1) Exploring topics in parasitology [188] and microbiology (e.g., biofilm formation, microbe distribution within a niche [189] [190] [191] [192] , host interaction with the microbiome [64
Hydrogel-embedding of fragile samples, b followed by gentle, passive wholeorgan clearing to maintain bacterial colonization Extending the imaging depth range and resolution for optical coherence tomography [194] [195] [196] [197] and photoacoustic tomography [140] [141] [142] 144, [198] [199] [200] [201] [202] [203] [204] [205] Future prospects for optically clearing living tissue with optical and/or contrast clearing reagents (e.g., varying ratios of PEG-400, DMSO, and/or glycerol) mapping distributed networks, such as those recruited by deep brain stimulation [92] [93] [94] [95] [96] [97] . Furthermore, engineered vectors that label discrete cell populations could be put to immediate use, for example in elucidating points of contact between major somatic sensory nerves and the CNS, or in mapping the autonomic motor branch of the PNS to better understand metabolic and endocrine disorders.
Despite these and other labeling technologies, it remains difficult to create maps for phenotypically distinct fine axons that run in bundles throughout the brain when the traditional method involves sectioning the tissue into paper-thin slices, imaging each slice, and recovering the 3D perspective with imaging software: it is slow, tedious, costly, and error prone. Over the past decade there has been a surge in methods for increasing the transparency of thick mammalian tissue samples and whole organs so that they may be examined intact (Table 2) . Here, the scientific value of fluorescencepreserving tissue clearing for vector engineering is also apparent: the ability to process major organs simultaneously and without sectioning (Figure 1b and c) will greatly facilitate transduction mapping of systemically delivered genes (Figure 1d ), including small-molecule tags and fluorescent labels.
Whole-organ and whole-body tissue-clearing methodologies
The original century-old tissue-clearing techniques [55,56] enable deep imaging into tissue without physical sectioning, but the harsh organic solvents damage cellular architecture and are incompatible with modern immunolabeling and fluorescence microscopy tools. Thus, the application of modern labeling technologies to ex vivo mapping studies requires new developments to render tissues transparent while also stabilizing critical macromolecules and preserving endogenous fluorescence (see Table 2 for a comprehensive list of major clearing protocols of the last decade). In particular, the CLARITY technique provides a method to further stabilize samples by anchoring tissue components in place using an interpolating hydrogel scaffold [ ]. While many clearing protocols are successful at removing lipids through detergent treatment alone, we have found that the porous structure of the tissue-hydrogel matrix, particularly when coupled to the driving force of detergent perfusion, facilitates rapid diffusion of solubilized lipids out of the tissue and the subsequent penetration of immunolabels into the remaining tissuehydrogel matrix. Furthermore, the utility of tissuehydrogel hybridization and detergent perfusion extends [102] , an undertaking which would be prohibitively slow via passive immersion-based clearing. Finally, after initial lipid extraction and/or solvation steps (Table 2 , chemical clearing), most tissue-clearing protocols employ a refractive-index homogenization step to minimize differences in light deflection by the heterogeneous tissue biomolecules (Table 3 , optical clearing). This is most commonly accomplished via immersing chemically cleared samples in a solution of matched refractive index, such as RIMS (Figure 2a) Table 3 ).
The ability to expediently process and analyze samples without sectioning has revolutionized modern histology.
For example, tissue clearing allows pathologists to map tumor cells in whole human biopsies and postmortem samples [28,32 ,33] . Likewise, the ability to conduct fast whole-body clearing, as granted by the perfusive force in the PARS methodology, opens new avenues for exploring small-molecule biodistribution, examining viral-vector tropism (Figure 1) , and tracing peripheral nerve networks to their target organs (Table 1) 104] ) and other decalcification methods [107] can facilitate mapping the three-dimensional architecture of skeletal tissue and stem cell niches [108] . Regardless of the clearing protocol used, all carry trade-offs in terms of the degree of optical transparency achieved, the maintenance of endogenous fluorescence, the preservation of cellular integrity, and the permeability of cleared tissue to macromolecule labels. Although clearing with organic solvents or with electrophoresis may deliver more rapid and effective clearing than passive methods involving immersion in aqueous solutions, these harsher methods may also hinder fluorescent imaging, prove incompatible with immunolabeling, or risk tissue damage (see Table 2 ). In selecting a specific protocol or merging aspects of multiple protocols [109] , researchers must consider their project objectives (e.g., imaging sparse epitopes, wholebody tract tracing) and experimental constraints (e.g., integration with smFISH or electron microscopy studies on cleared samples). Thus, this comprehensive list of 198 Tissue, cell and pathway engineering available protocols (Tables 2 and 3 ) will serve most experimental needs (Table 1) .
Toward structure-function mapping with tissue clearing
For tissue-clearing methods to reach their full potential, several major challenges must first be tackled. First, imaging: large tissue volumes require specialized microscopy; second, data analysis: meaningful data must be extracted from terabyte data sets; third, access to functional information: markers of activity must be preserved during tissue processing.
Regarding the extraction of functional information, a record of neuronal activity can be encoded via transcriptional or biochemical changes. For example, immediateearly-gene activation (e.g., through Targeted Recombination in Active Populations (TRAP) [110] [111] [112] [113] As we learn more about the transcriptional correlates of neuronal activity, quantitative and multiplexed RNA detection in intact tissue could also serve the role of extracting functional proxies from deceased tissue. Combinatorial labeling (barcoding) via single-molecule fluorescence in situ hybridization (smFISH) [119, 120] allows for simultaneous detection of mRNA transcripts for multiple genes within individual cells [121, 122 ]. Importantly, both HCR-based transcriptional analysis [123] [124] [125] and smFISH [32 ,121,122 ] have been validated in thick sections, wherein tissue clearing and the controlled swelling of tissue-hydrogels can improve single-transcript resolution through reducing background and physically separating single-molecule labels. Further enlargement of the optical space within a cell, either for fluorescently barcoding multiple transcripts or for examining single-cell morphology, may be achieved through recent protocols (e.g., ExM [72 ] , ePACT [41 ] ) that expand tissue 4-fold or more with the possibility to retain endogenous fluorescence (Figure 2c and d for ePACT; [41  ] ). Combined, these evolving technologies raise the possibility of single-cell transcriptomics with preserved spatial information. By applying high-resolution microscopy [58-60,126] to the detection of mRNA-binding probes (e.g., single-molecule hybridization chain reaction (smHCR) probes with high signal-to-noise [123] [124] [125] ) in cleared and, if needed, expanded tissue, scientists will be able to achieve more robust single-molecule RNA detection 200 Tissue, cell and pathway engineering and hence quantitative data for transcriptional profiling of intact circuits across organs [121, 122 ] .
Outlook
Studies in naturally transparent organisms have recently progressed to real-time monitoring of neuronal activity during controlled behavior via light-gated and light-emitting tools [114 ,127] . Although the protocols for tissue stabilization and lipid removal described above can produce samples with sufficient transparency for intact tissue imaging and rapid tissue phenotyping, these methods are limited to ex vivo use. Transparent or not, deceased tissue can offer only a static picture of neuronal connections. Even with a connectome in hand as a road-map for cellular networks, we would still be far from understanding the brain. For example, neuropeptides and hormones can act at a distance disregarding explicit wiring [128] [129] [130] , parallel pathways within a network can result in degeneracy in circuit function [131] , and apparent structural connectivity (e.g., as elucidated via GRASP [132] ) does not imply active synaptic connectivity [133] . A crucial next step will involve registering the three-dimensional information obtained through tissue-clearing with either ex vivo or in vivo cellular activity mapping. Compatible with cleared tissue imaging, methods such as TRAP [110] [111] [112] [113] and smFISH [32 ,121] enable the permanent tagging of recently active cells in thick tissues. This snapshot only captures a single time point, however. What remains to be developed is a method for time-stamping signaling events across bulk cell populations such that the time-varying metabolic information from a single-cell's lifetime can be retrieved and crosscorrelated to the metabolic records of all neighboring cells. To this end, single-cell transcriptomics [134, 135] and 'molecular ticker tapes' (i.e., an engineered DNA polymerase mis-incorporates nucleotides into a DNA 'ticker tape' based on spikes in ion concentration [136] [137] [138] ) represent two areas of promise.
A second approach under development aims to bring the CLARITY concept to living tissue. Namely, instead of altering tissue to reduce light-scattering, scientists are recruiting the power of ultrasound focusing at depth to deliver and collect light noninvasively from living tissue. Methods such as Time-Reversal Ultrasound-Encoded (TRUE) focusing aim to correct the light-wavefront in scattering tissue [141] and currently enable focusing at depth within ex vivo tissue [139, 142] . Because of its high sensitivity to motion, challenges remain in using TRUE for noninvasive deep-tissue imaging and light delivery in vivo [140] . One possibility is to combine advances in optical imaging, such as TRUE, with the application of gentle tissue clearing reagents in vivo to decrease autofluorescent background and homogenize the refractive index [143, 144] .
Bringing 'clarity' to living tissue, when combined with developments in labeling, imaging, and computation, will enable mapping of anatomical and functional connectivity and will illuminate the workings of intact circuits with high temporal precision. Although whole-body imaging is still a nascent technology, analysis of the resulting volumetric datasets will convey a level of scientific understanding that cannot be replicated in a two-dimensional context. Akin to previous work in the nematode and zebrafish, large-scale tissue clearing represents a first step toward a hermeneutic approach to mammalian biology.
Conflict of interest
California Institute of Technology filed intellectual property for some of the technologies described with authors as inventors. 
References and recommended reading

21.
Ke M-T, Fujimoto S, Imai T: SeeDB: a simple and morphologypreserving optical clearing agent for neuronal circuit reconstruction. Nat Neurosci 2013, 16:1154-1161. A passive clearing method based on immersion in aqueous fructose solutions of high refractive index. SeeDB minimizes tissue deformation and is faster than comparable methods (e.g., ScaleA2), although complete tissue transparency for deep imaging can be difficult to achieve, and the ability to immunolabel thick tissues is limited. [204] [205] [206] [207] [208] [209] . Introduces a novel selection platform for identifying adeno-associated viruses (AAVs) that can be delivered systemically and more efficiently transduce genetically defined cell populations. The methodology (CRE-ATE) eliminates the need for lengthy selection steps traditionally used in panning capsid libraries. As proof-of-principle of the CREATE platform, the isolation of an engineered AAV variant, PHP.B, capable of crossing the blood-brain barrier and conferring efficient CNS transduction is described.
54.
Sun Y, Nguyen AQ, Nguyen JP, Le L, Saur D, Choi J, Callaway EM, Xu X: Cell-type-specific circuit connectivity of hippocampal CA1 revealed through Cre-dependent rabies tracing. Cell Rep 2014, 7:269-280. A depiction of how the monosynaptic retrograde spread of glycoprotein (G)-deleted rabies virus can achieve improved cell-type specificity for circuit tracing through EnvA pseudtyping, crossing Cre driver lines with Cre-dependent TVA-expressing mice, and cell-specifically delivering the G transgene using Cre-dependent AAV. 
